Successful Alectinib Treatment Administered by Mixing With a Soft Diet in a Patient With Non–Small-Cell Lung Cancer With Severe Dysphagia

Abstract

Get full access to this article

View all access options for this article.

References

Wong

DWS

Leung

ELH

KKT

, et al. The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS. Cancer. 2009;115:1723-1733. doi:10.1002/cncr.24181

Petrelli

Lazzari

Ardito

, et al. Efficacy of ALK inhibitors on NSCLC brain metastases: a systematic review and pooled analysis of 21 studies. PLoS One. 2018;13:e0201425. doi:10.1371/journal.pone.0201425

Kwok

Tam

TCC

Lui

MMS

Lam

DCL

JCM

. Control of brain metastases with alectinib in anaplastic lymphoma kinase-rearranged lung cancer. Respirol Case Rep. 2017;5:e00224. doi:10.1002/rcr2.224

Tomasini

Egea

Souquet-Bressand

Greillier

Barlesi

Alectinib in the treatment of ALK-positive metastatic non-small cell lung cancer: clinical trial evidence and experience with a focus on brain metastases. Ther Adv Respir Dis. 2019;13:1753466619831906. doi:10.1177/1753466619831906